Divalproex Sodium: Package Insert and Label Information (Page 8 of 8)

Package/Label Display Panel

Once-Daily Dosing

Divalproex Sodium Extended-Release Tablets, USP

500 mg*

10 Tablets

Bag label
(click image for full-size original)
DIVALPROEX SODIUM divalproex sodium tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:55154-2345(NDC:0904-7182)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DIVALPROEX SODIUM (VALPROIC ACID) VALPROIC ACID 500 mg
Inactive Ingredients
Ingredient Name Strength
AMMONIA
ETHYL ACRYLATE
METHACRYLIC ACID — METHYL METHACRYLATE COPOLYMER (1:1)
HYPROMELLOSE, UNSPECIFIED
FERROSOFERRIC OXIDE
ISOPROPYL ALCOHOL
LACTOSE MONOHYDRATE
POLYETHYLENE GLYCOL, UNSPECIFIED
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
BUTYL ALCOHOL
POLYVINYL ALCOHOL, UNSPECIFIED
PROPYLENE GLYCOL
SHELLAC
SILICON DIOXIDE
TALC
TITANIUM DIOXIDE
Product Characteristics
Color white Score no score
Shape CAPSULE Size 21mm
Flavor Imprint Code AN;757
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:55154-2345-0 10 BLISTER PACK in 1 BAG contains a BLISTER PACK
1 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK This package is contained within the BAG (55154-2345-0)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203730 06/01/2015
Labeler — Cardinal Health 107, LLC (118546603)

Revised: 04/2023 Cardinal Health 107, LLC

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

https://druginserts.com/lib/rx/meds/divalproex-sodium-30/page/8/

Clinical Trials

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.